• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: anti-HER2 bispecific antibody drug conjugate
Date Designated: 07/06/2016
Orphan Designation: Treatment of ovarian cancer
Orphan Designation Status: Designated/Withdrawn
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Zymeworks Inc.
18 West Mercer Street
Suite 370
Seattle, Washington 98119
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-